Mpox Found in North Carolina Sewage: What to Know
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
Health providers and the public have been urged to be on the alert for mpox cases after particles were detected in several sewage samples in North Carolina.
The risk to the public is low at this time, the North Carolina Department of Health and Human Services (NCDHHS) said in a news release on Tuesday.
Why It Matters
Mpox, previously called monkeypox, is a rare disease. Part of the same family as the virus that causes smallpox, it is caused by a type of virus typically found in West and Central Africa. It is "primarily spread by prolonged close contact, typically skin-to-skin, often during sexual activity," according to the NCDHHS.
Early symptoms include fever, tiredness, headaches and sometimes a sore throat or cough. Those who contract the virus often develop a rash that changes over time (from flat spots to raised bumps, blisters and scabs). The process usually takes between two and three weeks, and those who are infected are contagious until all scabs heal and new skin forms.
What To Know
North Carolina's detections were found in wastewater samples collected on March 25, March 28 and April 8 from a treatment plant in Greenville.
They were all clade I—one of the two genetic types of the virus, the other being clade II. To date, only four clade I cases have been reported in the U.S.
"These detections mean there was possibly at least one person with an undiagnosed or unreported clade I mpox infection present or traveling through the Greenville area around the time of these detections," the NCDHHS said.
The results were found by the North Carolina Wastewater Monitoring Network, which was launched in 2021 to help improve information about the spread of certain viruses.
Samples are collected routinely from 35 wastewater treatment plants across the state and tested for specific viruses, including SARS-CoV-2 (the virus that causes COVID-19), influenza and respiratory syncytial virus.
This year has already seen two mpox cases identified in North Carolina. Both were clade II.
This colorized electron microscope image provided by the National Institute of Allergy and Infectious Diseases in 2024 shows mpox virus particles, green, found within infected cultured cells, blue. The virus particles are in various stages...
This colorized electron microscope image provided by the National Institute of Allergy and Infectious Diseases in 2024 shows mpox virus particles, green, found within infected cultured cells, blue. The virus particles are in various stages of maturity, which accounts for differences in shape. More
AP
What People Are Saying
Dev Sangvai, North Carolina's Health and Human Services secretary, said in the news release on Tuesday: "The detection of clade I mpox virus in wastewater surveillance tells us the virus is potentially here in our state, even though no cases have been reported and confirmed. We encourage health care providers to be on the lookout for mpox cases and we encourage people who are at higher risk to protect themselves by getting vaccinated."
What Happens Next
The NCDHHS has asked all North Carolina health care providers to consider mpox in patients who show compatible symptoms.
If you think you are exhibiting symptoms or have had close contact with someone who has mpox, you should visit your health care provider.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
37 minutes ago
- CNBC
FDA may pull authorization of Pfizer's Covid vaccine for children under 5
The Food and Drug Administration is weighing revoking its authorization of Pfizer's Covid-19 vaccine for healthy children under the age of 5, the drugmaker confirmed to CNBC on Tuesday. The move could leave many kids with no available shot against the virus, as jabs from Moderna and Novavax are cleared for more limited populations. While Covid typically causes mild symptoms in most children, others, such as infants under 1 or those with certain health conditions, can be at a higher risk of severe illness and hospitalization. If the FDA pulls the authorization, it would add to a string of recent efforts by U.S. health agencies to change and undermine immunization policy since Health and Human Services Secretary Robert F. Kennedy Jr. — a prominent vaccine skeptic — took the helm. HHS did not immediately respond to a request for comment. The FDA told Pfizer it might not renew its longstanding emergency use authorization for children aged 6 months to 4 years, the company said in a statement. Pfizer said it has requested the authorization to remain in place for the upcoming fall and winter season and is "currently in discussions with the agency on potential paths forward." The company said that the FDA's "deliberations" are not related to the safety and efficacy of the shot, "which continues to demonstrate a favorable profile." The Guardian first reported on the FDA's potential move. Moderna is working with the Centers for Disease Control and Prevention to boost supplies of its own Covid shot for children, the Guardian reported on Saturday. In July, the FDA granted full approval to Moderna's Covid vaccine for children — but only for those with health conditions that may put them at increased risk of severe illness if they become infected. Both shots from Moderna and Pfizer user messenger RNA technology. Kennedy has targeted those vaccines in the past, filing a petition in May 2021 demanding that the agency revoke authorization of the jabs. Meanwhile, Novavax's protein-based shot has never been available for children under 12. In May, Kennedy announced that the Centers for Disease Control and Prevention has removed its recommendation of Covid vaccines for healthy children and pregnant women. But in updated guidance days later, the CDC said the shots "may" be given to those kids if a doctor agreed that it was necessary. Covid vaccines during pregnancy are now listed as "No Guidance/Not Applicable," where they were previously recommended for all pregnant adults.
San Francisco Chronicle
an hour ago
- San Francisco Chronicle
Shooter attacked CDC headquarters to protest COVID-19 vaccines
ATLANTA (AP) — The man who fired more than 180 shots with a long gun at the headquarters of the U.S. Centers for Disease Control and Prevention broke into a locked safe to get his father's weapons and wanted to send a message against COVID-19 vaccines, authorities said Tuesday. Documents found in a search of the home where Patrick Joseph White had lived with his parents 'expressed the shooter's discontent with the COVID-19 vaccinations,' Georgia Bureau of Investigation Director Chris Hosey said. White, 30, had written about wanting to make 'the public aware of his discontent with the vaccine,' Hosey added. White also had recently verbalized thoughts of suicide, which led to law enforcement being contacted several weeks before the shooting, Hosey said. He died at the scene Friday of a self-inflicted gunshot wound after killing DeKalb County Police Officer David Rose. The shooting reflects the dangers public health leaders have been experiencing around the country since anti-vaccine vitriol took root during the pandemic. Such rhetoric has been amplified as President Donald Trump's Health Secretary, Robert F. Kennedy Jr., repeatedly makes false and misleading statements about the safety of immunizations. 'We know that misinformation can be dangerous. Not only to health, but to those that trust us and those we want to trust,' Dr. Susan Monarez told CDC employees in an 'all-hands' meeting Tuesday, her first since the attack capped her first full week on campus as the CDC's director. 'We need to rebuild the trust together,' Monarez said, according to a transcript obtained by the AP. 'The trust is what binds us. In moments like this, we must meet the challenges with rational, evidence based discourse spoken with compassion and understanding. That is how we will lead.' White's parents have fully cooperated with the investigation of their son, who had no known criminal history, Hosey said at the Tuesday news briefing. With a search warrant at the family's home in the Atlanta suburb of Kennesaw, authorities recovered written documents and electronic devices that are being analyzed. Investigators also recovered five firearms, including a gun of his father's that he used in the attack, Hosey said. White did not have a key to the gun safe, Hosey said: 'He broke into it.' CDC security guards stopped White from driving into the campus on Friday before he parked near a pharmacy across the street and opened fire from a sidewalk. The bullets pierced 'blast-resistant' windows across the campus, pinning employees down during the barrage. More than 500 shell casings were recovered, the GBI said. In the aftermath, CDC officials are assessing campus security and encouraging staff to alert authorities to any new threats, including those based on misinformation regarding the CDC and its vaccine work. 'We've not seen an uptick, although any rhetoric that suggests or leads to violence is something we take very seriously.' said FBI Special Agent Paul Brown, who leads the agency's Atlanta division. 'This is a targeted attack on the CDC related to COVID-19," Williams said. 'All indications are that this was an isolated event involving one individual.' The fact that CDC's security stopped him from entering the campus 'prevented what I can only imagine to be a lot of casualties," Williams said. 'Nearly 100 children at the childcare center were reunited with their parents at the end of the night,' he said. "The protections we have in place did an excellent job.' Kennedy toured the CDC campus on Monday, accompanied Monarez. 'No one should face violence while working to protect the health of others,' Kennedy said in a statement Saturday, without addressing the potential impact of anti-vaccine rhetoric. Kennedy refused to directly answer when asked during an interview with Scripps News on Monday what message he had for CDC employees who are worried about the culture of misinformation and skepticism around vaccines. Although law enforcement officials have made clear the shooter was targeting the public health agency over the COVID-19 vaccine, Kennedy said in the interview that not enough was known about his motives. He described political violence as 'wrong,' but went on to criticize the agency's response to the COVID-19 pandemic. "The government was overreaching in its efforts to persuade the public to get vaccinated and they were saying things that are not always true,' Kennedy said. Some unionized CDC employees called for more protections, and some who recently left amid widespread layoffs squarely blamed Kennedy.
Politico
2 hours ago
- Politico
Bhattacharya and Kennedy split on mRNA cuts
AROUND THE AGENCIES National Institutes of Health Director Jay Bhattacharya is making the case that mRNA vaccine technology is 'promising, but not yet ready for prime time.' He cites a lack of public trust in the technology as the reason his boss, Health Secretary Robert F. Kennedy Jr.,recently canceled $500 million in mRNA vaccine development projects. Bhattacharya weighed in on Kennedy's decision in a conversation over the weekend with Steve Bannon, the longtime Trump ally and prominent MAGA figure, on Bannon's 'War Room' podcast: 'The reason that he did that — and I think it's very important for people to understand — as far as public health goes for vaccines, the mRNA platform is no longer viable,' Bhattacharya said. 'You can't have a platform where such a large fraction of the population distrusts the platform, if you're going to use it for vaccines, and expect it to work.' But, but, but: Kennedy, who has long been suspicious of the mRNA vaccine platform, offered an explanation for the funding cuts that contradicts Bhattacharya's reasoning. 'After reviewing the science and consulting top experts at NIH and FDA, HHS has determined that mRNA technology poses more risk than benefits for these respiratory viruses,' Kennedy said in a video posted on social media last week, referring to Covid-19 and flu mRNA vaccines. Big picture: Scientists and drugmakers worry that Kennedy's skepticism of mRNA could stifle cancer treatment developments, our Lauren Gardner reports. mRNA technology can instruct the immune system to attack problem proteins, so it holds promise as a customized treatment for rare cancers and diseases. As such, dozens of mRNA therapies are being studied or are in the drug-development pipeline. Bhattacharya seemed aware of the technology's use beyond flu and Covid vaccines. After telling Bannon that mRNA technology wasn't ready for widespread vaccine use, he added: 'For cancer, maybe it's another story.' WELCOME TO FUTURE PULSE This is where we explore the ideas and innovators shaping health care. A swarm of jellyfish shut down reactors at a French nuclear power station, Ketrin Jochecová, our POLITICO colleague in Europe, reports. Share any thoughts, news, tips and feedback with Ruth Reader at rreader@ or Erin Schumaker at eschumaker@ Want to share a tip securely? Message us on Signal: RuthReader.02 or ErinSchumaker.01. OPERATING ROOM A large-scale study of New York's Mount Sinai Health System suggests that artificial intelligence could help emergency departments better handle their patient loads. In the study, researchers from Mount Sinai trained an AI model on 1.8 million emergency department visits between January 2019 and December 2023. Then they tested the model by comparing it with two months' worth of nurse triage assessments of nearly 50,000 patient visits across the system's urban and suburban hospitals. The result: Nurse predictions were 81.6 percent accurate, while the AI model's assessments were 85.4 percent accurate. The study, published in the journal Mayo Clinic Proceedings: Digital Health in July, had a few limitations, the authors noted, including that the research was conducted at a single health system over a short time span. Outcomes might differ in another setting, and longer-term trends could yield different results. Bird's eye view: 'The strength of this approach is its ability to turn complex data into timely, actionable insights for clinical teams — freeing them up to focus less on logistics and more on delivering the personal, compassionate care that only humans can provide,' Dr. Eyal Klang, study co-author and director of the Generative AI Research Program at Mount Sinai, said in a statement.
